Loading SRTOY…
Loading profile data…Frequently asked questions about SRTOY
What does Sartorius Stedim Biotech S.A. (SRTOY) do?
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentra
Where does SRTOY trade?
Sartorius Stedim Biotech S.A. (SRTOY) trades on the Other OTC.
What sector is SRTOY in?
Sartorius Stedim Biotech S.A. (SRTOY) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Sartorius Stedim Biotech S.A.?
Rene Faber is the chief executive officer of Sartorius Stedim Biotech S.A. (SRTOY).
Where is Sartorius Stedim Biotech S.A. headquartered?
Sartorius Stedim Biotech S.A. is headquartered in France.
When did SRTOY go public?
Sartorius Stedim Biotech S.A. (SRTOY) completed its initial public offering in 2022.
Is SRTOY an ADR?
Yes — SRTOY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Sartorius Stedim Biotech S.A. reporting and dividends follow the underlying issuer.